MT
Mach5 Therapeutics, Inc.
The startup develops therapeutics targeting immune-mediated inflammatory and fibrotic diseases, utilizing specific biological pathways to modulate immune responses. Their treatments aim to improve patient outcomes for chronic conditions where the immune system mistakenly attacks healthy tissue.
- Biotechnology
Updated 5 months ago
Funding
Funding rounds are not available yet.
Founders
Founder details are not available yet.
Product
Features
- The startup develops therapeutics targeting immune-mediated inflammatory and fibrotic diseases, utilizing specific biological pathways to modulate immune responses. Their treatments aim to improve patient outcomes for chronic conditions where the immune system mistakenly attacks healthy tissue.